Disclosures: J.K. received drugs from Abbott Pharmaceuticals for a clinical trial in SMA, is a paid consultant for Alexion Pharmaceuticals and Cytokinetics, and is funded by the National Institutes of Health (NIH U10 NS77382-2 for NeuroNEXT). B.E. received drugs from Abbott Pharmaceuticals for a clinical trial in SMA. S.R. has received grants from Families of SMA. K.K has received grant funding from the Families of SMA. G.A. receives funding from NIH/NINDS. B.L. received grants from Families of SMA and the National Center for Research Resources (UL1RR025764 to the University of Utah Center for Clinical and Translational Science). K.S. has contracts with ISIS Pharmaceuticals, Inc., Orphamed, and Biomarin for clinical trials and receives grant support from the NIH (R01-HD69045 from NICHD and U10 NS077305 from NINDS), the Muscular Dystrophy Association, and the Alternating Hemiplegia of Childhood Foundation. The remaining authors have no disclosures to report.
SMA valiant trial: A prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy
Version of Record online: 13 JUN 2013
Copyright © 2013 Wiley Periodicals, Inc.
Muscle & Nerve
Volume 49, Issue 2, pages 187–192, February 2014
How to Cite
Kissel, J. T., Elsheikh, B., King, W. M., Freimer, M., Scott, C. B., Kolb, S. J., Reyna, S. P., Crawford, T. O., Simard, L. R., Krosschell, K. J., Acsadi, G., Schroth, M. K., D'Anjou, G., LaSalle, B., Prior, T. W., Sorenson, S., Maczulski, J. A., Swoboda, K. J. and for the Project Cure Spinal Muscular Atrophy Investigators Network (2014), SMA valiant trial: A prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy. Muscle Nerve, 49: 187–192. doi: 10.1002/mus.23904
- Issue online: 16 JAN 2014
- Version of Record online: 13 JUN 2013
- Accepted manuscript online: 16 MAY 2013 07:12AM EST
- Manuscript Accepted: 7 MAY 2013
- Families of Spinal Muscular Atrophy and also by grants from the Center for Clinical and Translational Sciences, University of Utah . Grant Number: UL1RR025764
- Center for Clinical and Translational Sciences, Ohio State University . Grant Number: UL1RR025755
This article includes Supplementary Material available via the internet at http://www.mrw.interscience.wiley.com/suppmat/0148–639X/suppmat
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.